http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108912123-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-30
filingDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108912123-B
titleOfInvention Method for synthesizing chiral hexa-membered carbocyclic purine nucleoside through asymmetric [3+3] cyclization reaction
abstract The invention discloses a method for synthesizing chiral hexatomic carbocyclic purine nucleoside through asymmetric [3+3] cyclization reaction, which belongs to the field of asymmetric synthesis in organic chemistry. α -purine-substituted acetone and β, gamma-unsaturated ketonic acid ester are taken as raw materials, chiral thiourea is taken as a catalyst, and a chiral hexatomic carbocyclic purine nucleoside compound is obtained after reaction.
priorityDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452599334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415846230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453375181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135433604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID455041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723790

Total number of triples: 57.